Brintellix
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
In July 2015, the US Food and Drug Administration (FDA) published a drug safety communication regarding errors in prescribing and…
OBJECTIVE: The Objective of this selective EBM review is to determine where or not, “Is Incidence of Nausea Influenced by…
Vortioxetine (Brintellix): a new serotonergic antidepressant.
* The Food and Drug Administration is warning health care providers about two drugs with similar-sounding brand names: Brintellix…
Current evidence does not support the routine use of vortioxetine in the treatment of depression. Family physicians most often…
CONTEXT
Vortioxetine (Lu AA21004) is an antidepressant with a mechanism of action thought to be related to a combination of 2…
BACKGROUND
This 8-week, randomized, double-blind, placebo-controlled study, conducted August 2010-May 2012 in the United States…
Vortioxetine (Brintellix®) is a serotonin (5-HT) transporter inhibitor that also acts on several 5-HT receptors, such as the 5…
In the final months of 2013, the US Food and Drug Administration approved two new antidepressant formulations. This column…